Valbenazine Will Be Used to Reduce Tardive Dyskinesia Symptoms

June 2017

Valbenazine (Ingrezza, in-GREH-zah) will be the first med approved to treat tardive dyskinesia.

Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia...involuntary lip smacking, facial grimaces, etc.

It's usually associated with higher doses, longer durations, and higher-potency typical antipsychotics, such as haloperidol.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote